Navigation Links
Pandemic study of 1918-1919 outbreak provides background and death rates for 14 European countries
Date:4/30/2009

A French study of the 1918-1919 influenza pandemic, which analysed mortality rates in approximately three-quarters of the European population, has concluded that it is unlikely that the virus, often described as Spanish Flu, originated in Europe.

Published in the May issue of Influenza and Other Respiratory Viruses, the research shows a high degree of synchronicity in the 14 countries studied, including Spain, with the flu peaking in October to November 1918.

The study, carried out by a team from INSERM, the French National Institute for Health and Medical Research, provides invaluable background briefing for clinicians and media during the current pandemic alert.

Key facts highlighted by the research which can be viewed free online - include:

  • Overall deaths increased by 86 per cent in the 14 European countries studied during the 1918-1919 pandemic, with 1.98 million excess deaths recorded. When these figures were extrapolated to cover the 25 per cent of Europe not covered by the study, the figure reached 2.64 million.

  • Excess mortality rates for the individual countries covered by the INSERM analysis were: Bulgaria (102%), England and Wales (55%), Finland (33%), Sweden (74%), France (66%), Germany (73%), Italy (172%), Norway (65%), Denmark (58%), Portugal (102%), Scotland (57%), Spain (87%), Switzerland (69%) and The Netherlands (84%).

  • Figures for the worldwide death toll remain very imprecise. A first American report in 1927 suggested that the main 1918-1919 wave was responsible for 21 million deaths worldwide. A revised estimate in 1991 put the figure between 24.7 and 39.3 million and another in 2002 set the death toll at up to 100 million to take into account the lack of data in a large part of the world.

  • The authors point out that the source of the 1918 pandemic remains unclear. A recent analysis of the 1918 H1N1 genome failed to single out a particular location. Theories put forward by various researchers include Asia, a British army post in France in 1916, the USA and Spain.

  • The first reported pandemic was in 412 BC and the first attributed to influenza was in 1580. Since then 31 influenza pandemics have been reported, with the five most recent being in 1889, 1900, 1918, 1957 and 1968. The 1918 pandemic was the most deadly in modern history.

  • Other useful background information in the paper includes the start and finish dates of the pandemic outbreaks in the 14 countries studied, with graphs showing the peaks in each country.

Influenza and Other Respiratory Viruses is the first journal to specialise exclusively on influenza and other respiratory viruses and is edited by one of the world's leading flu experts, Dr Alan Hampson. It is the official journal of the International Society for Influenza and Other
Respiratory Virus Diseases (www.isirv.org), an independent scientific professional society promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases.


'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
3. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
4. New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact
5. Report highlights inadequate pandemic planning as a threat to EU security
6. AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic
7. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
8. Vical Expands Clinical Testing of DNA Vaccine Against H5N1 Pandemic Influenza
9. CEO Addresses Georgia Business Leaders About Developing Pandemic and Business Continuity Plans
10. iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning
11. Flu Pandemic: Is the U.S. Ready?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology: